scPharmaceuticals
SCPH
SCPH was delisted on the 6th of October, 2025.
85 hedge funds and large institutions have $141M invested in scPharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 16 reducing their positions, and 26 closing their positions.
687% more call options, than puts
Call options by funds: $614K | Put options by funds: $78K
131% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 16
5.02% more ownership
Funds ownership: 74.46% → 79.49% (+5%)
11% less funds holding
Funds holding: 95 → 85 (-10)
17% less capital invested
Capital invested by funds: $170M → $141M (-$29M)
35% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 26
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$6.04M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.9M |
| 3 |
Luther King Capital Management (LKCM)
Fort Worth,
Texas
|
+$2.42M |
| 4 |
PA
Perceptive Advisors
New York
|
+$1.92M |
| 5 |
BlackRock
New York
|
+$1.64M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$3.49M |
| 2 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$2.36M |
| 3 |
Walleye Capital
New York
|
-$2.17M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.01M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.46M |
SCPH Hedge Fund Activity: Q4 2024 in Review
85 of the 7,606 institutional investors tracked by Wall St. Rank reported a position in scPharmaceuticals (SCPH) for Q4 2024, worth a combined $141M — down 17% from $170M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of SCPH and 17 opened new positions — a net loss of 9 holders — while 16 trimmed existing stakes and 37 added.
The largest buyer was Morgan Stanley, adding an estimated $6.04M. The largest seller was AWM Investment Company, exiting entirely with an estimated $3.49M sold.
- 85 institutional investors held scPharmaceuticals (SCPH) as of Q4 2024, down from 95 in Q3 2024.
- Funds reported $141M of scPharmaceuticals stock for Q4 2024, down 17% quarter-over-quarter.
- 17 funds opened new scPharmaceuticals positions in Q4 2024 and 26 closed out, a net change of -9 holders.
- The largest scPharmaceuticals buyer in Q4 2024 was Morgan Stanley, an estimated $6.04M added.
- The largest scPharmaceuticals seller in Q4 2024 was AWM Investment Company, an estimated $3.49M sold.
Based on aggregated 13F filings for Q4 2024.